Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mg

NCT02485041 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Interaction Potentiation

Interventions

DRUG: Dapoxetine 30mg
DRUG: Mirodenafil 100mg

Sponsor

SK Chemicals Co., Ltd.